Anna Djos

944 citations

24 papers · 491 indexed · h-index 13

Impact in

Neurology top 5%
- Neuroblastoma Research and Treatments
Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism

Papers in ⓘ

Neurology 22
- Neuroblastoma Research and Treatments 22
- Neurofibromatosis and Schwannoma Cases 2
Cancer Research 11
- Cancer, Hypoxia, and Metabolism 10

Co-authors: Tommy Martinsson (22 shared papers)Per Kogner (18 shared papers)Helena Carén (5 shared papers)Ruth H. Palmer (7 shared papers)Bengt Hallberg (7 shared papers)Susanne Fransson (18 shared papers)Niloufar Javanmardi (8 shared papers)Rosa Noguera (5 shared papers)
Journals: Genes Chromosomes and Cancer (3 papers)Scientific Reports (2 papers)International Journal of Oncology (2 papers)Frontiers in Oncology (2 papers)Oncogene (2 papers)
Partner nations: Sweden Spain China

In The Last Decade

Anna Djos

21 papers receiving 488 citations

Peers

Countries citing papers authored by Anna Djos

Since Specialization

Citations

This map shows the geographic impact of Anna Djos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Djos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Djos more than expected).

Fields of papers citing papers by Anna Djos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Djos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Djos. The network helps show where Anna Djos may publish in the future.

Co-authors

The 25 scholars most cited alongside Anna Djos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anna Djos Line = papers co-authored together Anna Djos links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Anaplastic Lymphoma Kinase (ALK) regulates initiation of transcription of MYCN in neuroblastoma cells Oncogene ·Christina Schönherr, Kristina Ruuth, Sattu Kamaraj, C-L Wang, Hong‐Ling Yang, Valérie Combaret, Anna Djos, Tommy Martinsson, James G. Christensen, Ruth H. Palmer, Bengt Hallberg	2012	83
2	The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma Molecular Cancer ·Anna Djos, Tommy Martinsson, Per Kogner, Helena Carén	2012	62
3	Identification of epigenetically regulated genes that predict patient outcome in neuroblastoma BMC Cancer ·Helena Carén, Anna Djos, Maria Nethander, Rose‐Marie Sjöberg, Per Kogner, Camilla Enström, Staffan Nilsson, Tommy Martinsson	2011	59
4	MEK inhibitor trametinib does not prevent the growth of anaplastic lymphoma kinase (ALK)–addicted neuroblastomas Science Signaling ·Ganesh Umapathy, Jikui Guan, Dan Gustafsson, Niloufar Javanmardi, Diana Cervantes-Madrid, Anna Djos, Tommy Martinsson, Ruth H. Palmer, Bengt Hallberg	2017	41
5	Intragenic anaplastic lymphoma kinase (ALK) rearrangements: Translocations as a novel mechanism of ALK activation in neuroblastoma tumors Genes Chromosomes and Cancer ·Susanne Fransson, Magnus Hansson, Kristina Ruuth, Anna Djos, Ana P. Berbegall, Niloufar Javanmardi, Jonas Abrahamsson, Ruth H. Palmer, Rosa Noguera, Bengt Hallberg, Per Kogner, Tommy Martinsson	2014	34
6	Genetic Instability and Intratumoral Heterogeneity in Neuroblastoma with MYCN Amplification Plus 11q Deletion PLoS ONE ·Eva Villamón, Ana P. Berbegall, Marta Piqueras, Irene Tadeo, Victoria Castel, Anna Djos, Tommy Martinsson, Samuel Navarro, Rosa Noguera	2013	33
7	11q Deletion or ALK Activity Curbs DLG2 Expression to Maintain an Undifferentiated State in Neuroblastoma Cell Reports ·Joachim T. Siaw, Niloufar Javanmardi, Jimmy Van den Eynden, Dan E. Lind, Susanne Fransson, Angela Martinez‐Monleon, Anna Djos, Rose‐Marie Sjöberg, Malin Östensson, Helena Carén, Gunhild Trøen, Klaus Beiske, Ana P. Berbegall, Rosa Noguera, Wei‐Yun Lai, Per Kogner, Ruth H. Palmer, Bengt Hallberg, Tommy Martinsson	2020	28
8	METTL3 drives telomere targeting of TERRA lncRNA through m6A-dependent R-loop formation: a therapeutic target for ALT-positive neuroblastoma Nucleic Acids Research ·Roshan Vaid, Ketan Thombare, Akram Mendez, Rebeca Burgos‐Panadero, Anna Djos, Daniel Jachimowicz, Kristina Lundberg, Christoph Bartenhagen, Navinder Kumar, Conny Tümmler, Carina Sihlbom, Susanne Fransson, John Inge Johnsen, Per Kogner, Tommy Martinsson, Matthias Fischer, Tanmoy Mondal	2023	27
9	Comparative genetic study of intratumoral heterogenous MYCN amplified neuroblastoma versus aggressive genetic profile neuroblastic tumors Oncogene ·Ana P. Berbegall, Eva Villamón, Marta Piqueras, Irene Tadeo, Anna Djos, Peter F. Ambros, Tommy Martinsson, I.M. Ambros, Adela Cañete, Victoria Castel, S. Navarro, Rosa Noguera	2015	21
10	Analysis of ALK, MYCN, and the ALK ligand ALKAL2 (FAM150B/AUGα) in neuroblastoma patient samples with chromosome arm 2p rearrangements Genes Chromosomes and Cancer ·Niloufar Javanmardi, Susanne Fransson, Anna Djos, Ganesh Umapathy, Malin Östensson, Jelena Milosevic, Marcus Borenäs, Bengt Hallberg, Per Kogner, Tommy Martinsson, Ruth H. Palmer	2019	20
11	Estimation of copy number aberrations: Comparison of exome sequencing data with SNP microarrays identifies homozygous deletions of 19q13.2 and CIC in neuroblastoma International Journal of Oncology ·Susanne Fransson, Malin Östensson, Anna Djos, Niloufar Javanmardi, Per Kogner, Tommy Martinsson	2016	17
12	Amplification of CDK4 and MDM2: a detailed study of a high-risk neuroblastoma subgroup Scientific Reports ·Angela Martinez‐Monleon, Hanna Kryh Öberg, Jennie Gaarder, Ana P. Berbegall, Niloufar Javanmardi, Anna Djos, Marek Ussowicz, Sabine Taschner‐Mandl, Inge M. Ambros, Ingrid Øra, Bengt Sandstedt, Klaus Beiske, Ruth Ladenstein, Rosa Noguera, Peter F. Ambros, Lena Gordon Murkes, Gustaf Ljungman, Per Kogner, Susanne Fransson, Tommy Martinsson	2022	16
13	Low Frequency ALK Hotspots Mutations In Neuroblastoma Tumours Detected By Ultra-deep Sequencing: Implications For ALK Inhibitor Treatment Scientific Reports ·Niloufar Javanmardi, Susanne Fransson, Anna Djos, Rose‐Marie Sjöberg, Staffan Nilsson, Katarina Truvé, Per Kogner, Tommy Martinsson	2019	14
14	Sustained Response to Entrectinib in an Infant With a Germline ALKAL2 Variant and Refractory Metastatic Neuroblastoma With Chromosomal 2p Gain and Anaplastic Lymphoma Kinase and Tropomyosin Receptor Kinase Activation JCO Precision Oncology ·Diana Treis, Ganesh Umapathy, Susanne Fransson, Jikui Guan, Patricia Mendoza-García, Joachim T. Siaw, Sandra Wessman, Lena Gordon Murkes, Jakob Stenman, Anna Djos, Lotta Elfman, John Inge Johnsen, Bengt Hallberg, Ruth H. Palmer, Tommy Martinsson, Per Kogner	2022	12
15	Novel human-derived EML4-ALK fusion cell lines identify ribonucleotide reductase RRM2 as a target of activated ALK in NSCLC Lung Cancer ·Abdulmalik A. Bokhari, Wei‐Yun Lai, Anh T. Le, Jonatan L. Gabre, T-P. Chuang, Susanne Fransson, Bengt Bergman, Anna Djos, Nai-Kuang Chen, Tommy Martinsson, Jimmy Van den Eynden, Robert C. Doebele, Ruth H. Palmer, Bengt Hallberg, Ganesh Umapathy	2022	7
16	Aneuploidy in neuroblastoma tumors is not associated with inactivating point mutations in the STAG2 gene BMC Medical Genetics ·Anna Djos, Susanne Fransson, Per Kogner, Tommy Martinsson	2013	5
17	Identification of recurrent 3q13.31 chromosomal rearrangement indicates LSAMP as a tumor suppressor gene in neuroblastoma International Journal of Oncology ·Angela Martinez‐Monleon, Jennie Gaarder, Anna Djos, Per Kogner, Susanne Fransson	2023	4
18	Telomere Maintenance Mechanisms in a Cohort of High-Risk Neuroblastoma Tumors and Its Relation to Genomic Variants in the TERT and ATRX Genes Cancers ·Anna Djos, Ketan Thombare, Roshan Vaid, Jennie Gaarder, Ganesh Umapathy, Susanne E. Reinsbach, Kleopatra Georgantzi, Jakob Stenman, Helena Carén, Torben Ek, Tanmoy Mondal, Per Kogner, Tommy Martinsson, Susanne Fransson	2023	3
19	Loss of Chromosome Y in Neuroblastoma Is Associated With High‐Risk Disease, 11q‐Deletion, and Telomere Maintenance Genes Chromosomes and Cancer ·Anna Djos, Johanna Svensson, Jennie Gaarder, Ganesh Umapathy, Staffan Nilsson, Torben Ek, Hartmut Vogt, Kleopatra Georgantzi, Ingrid Øra, Catarina Träger, Per Kogner, Tommy Martinsson, Susanne Fransson	2024	2
20	Whole exome sequencing identifies KIF26B, LIFR and LAMC1 mutations in familial vesicoureteral reflux PLoS ONE ·Zsuzsa Bartik, Ulla Sillén, Anna Djos, Anna K. Lindholm, Susanne Fransson	2022	2

About Anna Djos

Anna Djos is a scholar working on Neurology, Cancer Research, Molecular Biology, Oncology and Urology, having authored 24 papers that have together received 491 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (22 papers), Cancer, Hypoxia, and Metabolism (10 papers), Cancer therapeutics and mechanisms (9 papers), Neuroendocrine Tumor Research Advances (5 papers), Lung Cancer Research Studies (5 papers), Neurofibromatosis and Schwannoma Cases (2 papers), Cell death mechanisms and regulation (2 papers) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Neurology (317 citations), Cancer Research (175 citations), Molecular Biology (330 citations), Oncology (126 citations) and Cell Biology (51 citations). Anna Djos has collaborated with scholars based in Sweden, Spain and China. Frequent co-authors include Tommy Martinsson, Per Kogner, Helena Carén, Ruth H. Palmer, Bengt Hallberg, Susanne Fransson, Niloufar Javanmardi, Rosa Noguera, Rose‐Marie Sjöberg and Ana P. Berbegall. Their work appears in journals such as Genes Chromosomes and Cancer, Scientific Reports, International Journal of Oncology, Frontiers in Oncology and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact